HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Fini Selected Research

Trimetazidine (Vastarel)

4/2011Trimetazidine improves exercise performance in patients with peripheral arterial disease.
4/2009Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
8/2007Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
11/2005Metabolic therapy for the diabetic patients with ischaemic heart disease.
2/2005Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
10/2004Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
3/2004[Quality of life in elderly patients with ischemic cardiopathy].
11/2003Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Fini Research Topics

Disease

15Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2002
9Chronic Obstructive Pulmonary Disease (COPD)
07/2019 - 12/2016
8Myocardial Ischemia (Ischemic Heart Diseases)
06/2010 - 11/2003
7Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2003
7Insulin Resistance
05/2020 - 12/2003
6Inflammation (Inflammations)
01/2019 - 04/2005
6Neoplasms (Cancer)
01/2016 - 12/2005
5Heart Failure
11/2015 - 09/2009
4Lung Neoplasms (Lung Cancer)
01/2019 - 06/2009
4Hypoxia (Hypoxemia)
01/2016 - 05/2010
4Cardiomyopathies (Cardiomyopathy)
04/2009 - 11/2003
3Alzheimer Disease (Alzheimer's Disease)
02/2022 - 01/2014
3Myocardial Infarction
01/2022 - 04/2009
3Stroke (Strokes)
01/2022 - 09/2004
3Type 2 Diabetes Mellitus (MODY)
05/2020 - 11/2003
3Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2020 - 03/2004
3Pain (Aches)
01/2020 - 09/2014
3Breast Neoplasms (Breast Cancer)
01/2015 - 11/2003
2Chronic Pain
11/2020 - 01/2014
2Hyperalgesia
11/2020 - 01/2020
2Hypertension (High Blood Pressure)
05/2020 - 03/2012
2Chronic Disease (Chronic Diseases)
02/2016 - 04/2014
2Atherosclerosis
04/2015 - 04/2005
2Ischemia
01/2008 - 03/2007
2Heart Diseases (Heart Disease)
11/2005 - 10/2004
2Erectile Dysfunction
02/2005 - 11/2003
1Parkinson Disease (Parkinson's Disease)
02/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022
1Proteostasis Deficiencies
02/2022
1Vascular System Injuries
01/2022
1Thrombosis (Thrombus)
01/2022
1Hyperlipidemias (Hyperlipidemia)
01/2022
1Hemorrhage
01/2022
1Virus Diseases (Viral Diseases)
12/2020
1COVID-19
12/2020
1Neuralgia (Stump Neuralgia)
11/2020
1Non-alcoholic Fatty Liver Disease
05/2020
1Hyperemia
01/2017
1Obesity
01/2017
1Prostatic Neoplasms (Prostate Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

8Trimetazidine (Vastarel)IBA
04/2011 - 11/2003
6Biomarkers (Surrogate Marker)IBA
02/2022 - 08/2015
6Estrogens (Estrogen)FDA Link
03/2007 - 01/2002
4NicotineFDA Link
12/2020 - 06/2009
4AntioxidantsIBA
11/2020 - 03/2009
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2019 - 06/2009
4Pharmaceutical PreparationsIBA
01/2017 - 01/2014
4Antihypertensive Agents (Antihypertensives)IBA
12/2016 - 03/2004
4Testosterone (Sustanon)FDA Link
11/2015 - 09/2009
4C-Reactive ProteinIBA
09/2005 - 09/2003
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 08/2016
3Sirtuin 3IBA
11/2020 - 03/2009
3Sildenafil Citrate (Viagra)FDA Link
01/2011 - 11/2003
3Hormones (Hormone)IBA
06/2010 - 03/2004
3Progestins (Progestagens)IBA
12/2006 - 11/2003
3Interleukin-6 (Interleukin 6)IBA
09/2005 - 09/2004
2Triglycerides (Triacylglycerol)IBA
01/2022 - 05/2020
2CholesterolIBA
01/2022 - 01/2002
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020 - 01/2016
2SirtuinsIBA
11/2020 - 01/2016
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2019 - 01/2019
2GlucocorticoidsIBA
04/2019 - 02/2016
2tiboloneIBA
01/2017 - 09/2005
2Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2017 - 01/2014
2Therapeutic UsesIBA
01/2017 - 01/2011
2NF-kappa B (NF-kB)IBA
01/2016 - 08/2011
2LigandsIBA
05/2012 - 08/2011
2Matrix Metalloproteinases (MMPs)IBA
08/2011 - 05/2010
2Nonesterified Fatty Acids (NEFA)IBA
08/2007 - 11/2005
2Endothelin-1 (Endothelin 1)IBA
03/2007 - 10/2002
2Estradiol (Delestrogen)FDA LinkGeneric
02/2006 - 10/2002
2LipidsIBA
05/2005 - 06/2003
2Glucose (Dextrose)FDA LinkGeneric
05/2005 - 11/2003
1SolutionsIBA
01/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1HDL CholesterolIBA
05/2020
1Excipients (Suspending Agents)IBA
05/2020
1CarrageenanIBA
01/2020
1Biological ProductsIBA
07/2019
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
04/2019
1FlavonoidsIBA
01/2019
1GoldIBA
01/2017
1AnticoagulantsIBA
12/2016
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
12/2016
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
12/2016
1AngiotensinogenIBA
08/2016
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
08/2016
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2016
1Angiotensin Receptor AntagonistsIBA
08/2016
1Anti-Bacterial Agents (Antibiotics)IBA
02/2016
1Oxidoreductases (Dehydrogenase)IBA
02/2016
1Coenzyme A (CoA)IBA
02/2016
1AndrogensIBA
01/2016
1Estrogen ReceptorsIBA
01/2016

Therapy/Procedure

23Therapeutics
02/2022 - 09/2003
4Hormone Replacement Therapy (Therapy, Hormone Replacement)
04/2005 - 01/2002
2Polypharmacy
04/2014 - 06/2013
1Lab-On-A-Chip Devices
02/2022
1Secondary Prevention
01/2022